Name | Number of supported studies | Average coverage | |
---|---|---|---|
adipocyte | 5 studies | 19% ± 5% | |
epithelial cell | 3 studies | 21% ± 4% | |
glutamatergic neuron | 3 studies | 30% ± 12% |
Insufficient scRNA-seq data for expression of GSDMB at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
intestine | 99% | 2668.05 | 961 / 966 | 98% | 40.93 | 519 / 527 |
bladder | 100% | 1171.90 | 21 / 21 | 95% | 28.25 | 481 / 504 |
stomach | 97% | 1468.20 | 350 / 359 | 96% | 32.81 | 275 / 286 |
pancreas | 98% | 644.32 | 322 / 328 | 94% | 33.64 | 167 / 178 |
uterus | 99% | 785.36 | 168 / 170 | 87% | 17.80 | 399 / 459 |
lung | 100% | 1125.20 | 577 / 578 | 85% | 16.42 | 979 / 1155 |
liver | 100% | 3339.38 | 226 / 226 | 82% | 10.05 | 333 / 406 |
thymus | 100% | 1451.48 | 651 / 653 | 82% | 11.51 | 494 / 605 |
esophagus | 95% | 622.39 | 1370 / 1445 | 78% | 39.21 | 143 / 183 |
breast | 100% | 1451.48 | 459 / 459 | 62% | 9.64 | 688 / 1118 |
ovary | 99% | 883.36 | 179 / 180 | 56% | 6.11 | 239 / 430 |
prostate | 100% | 1537.73 | 245 / 245 | 48% | 4.09 | 241 / 502 |
brain | 94% | 900.85 | 2473 / 2642 | 44% | 3.24 | 313 / 705 |
kidney | 94% | 616.24 | 84 / 89 | 39% | 3.19 | 348 / 901 |
skin | 97% | 812.46 | 1760 / 1809 | 15% | 1.03 | 72 / 472 |
spleen | 100% | 1911.64 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 22.62 | 1 / 1 |
adipose | 100% | 1543.15 | 1200 / 1204 | 0% | 0 | 0 / 0 |
peripheral blood | 94% | 933.30 | 875 / 929 | 0% | 0 | 0 / 0 |
blood vessel | 94% | 544.65 | 1255 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 86% | 11.08 | 25 / 29 |
tonsil | 0% | 0 | 0 / 0 | 82% | 9.60 | 37 / 45 |
heart | 69% | 291.90 | 595 / 861 | 0% | 0 | 0 / 0 |
adrenal gland | 27% | 95.74 | 69 / 258 | 5% | 0.38 | 12 / 230 |
muscle | 22% | 72.40 | 174 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 4% | 0.22 | 3 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0031640 | Biological process | killing of cells of another organism |
GO_0070269 | Biological process | pyroptotic inflammatory response |
GO_0042742 | Biological process | defense response to bacterium |
GO_0005886 | Cellular component | plasma membrane |
GO_0005737 | Cellular component | cytoplasm |
GO_0005546 | Molecular function | phosphatidylinositol-4,5-bisphosphate binding |
GO_0001786 | Molecular function | phosphatidylserine binding |
GO_0070273 | Molecular function | phosphatidylinositol-4-phosphate binding |
Gene name | GSDMB |
Protein name | Gasdermin-B (Gasdermin-like protein) [Cleaved into: Gasdermin-B, N-terminal (GSDMB-NT) (p30); Gasdermin-B, C-terminal (GSDMB-CT) (p16)] Gasdermin B (Gasdermin-like isoform GSDML3) Gasdermin B Gasdermin B (Gasdermin-like isoform GSDML2) Gasdermin B (Gasdermin-like isoform GSDML4) |
Synonyms | PRO2521 PP4052 GSDML |
Description | FUNCTION: [Gasdermin-B]: Precursor of a pore-forming protein that acts as a downstream mediator of granzyme-mediated cell death . This form constitutes the precursor of the pore-forming protein: upon cleavage, the released N-terminal moiety (Gasdermin-B, N-terminal) binds to membranes and forms pores, triggering pyroptosis . Also acts as a regulator of epithelial cell repair independently of programmed cell death: translocates to the plasma membrane and promotes epithelial maintenance and repair by regulating PTK2/FAK-mediated phosphorylation of PDGFA . .; FUNCTION: [Gasdermin-B, N-terminal]: Pore-forming protein produced by cleavage by granzyme A (GZMA), which causes membrane permeabilization and pyroptosis in target cells of cytotoxic T and natural killer (NK) cells . Key downstream mediator of granzyme-mediated cell death: (1) granzyme A (GZMA), delivered to target cells from cytotoxic T- and NK-cells, (2) specifically cleaves Gasdermin-B to generate this form . After cleavage, moves to the plasma membrane, homooligomerizes within the membrane and forms pores of 10-15 nanometers (nm) of inner diameter, triggering pyroptosis . The different isoforms recognize and bind different phospholipids on membranes, promoting cell death of different target cells . .; FUNCTION: [Isoform 4]: Precursor of a pore-forming protein that acts as a downstream mediator of granzyme-mediated cell death and mediates pyroptosis . Following cleavage and activation by granzyme A (GZMA), the N-terminal part binds to membrane inner leaflet lipids, homooligomerizes within the human plasma membrane and forms pores of 10-15 nanometers (nm) of inner diameter, triggering pyroptosis . Recognizes and binds membrane inner leaflet lipids of human cells, such as phosphatidylinositol 4-phosphate, phosphatidylinositol 5-phosphate, bisphosphorylated phosphatidylinositols, such as phosphatidylinositol (4,5)-bisphosphate, and more weakly to phosphatidic acid . Also binds sufatide, a component of the apical membrane of epithelial cells . .; FUNCTION: [Isoform 6]: Precursor of a pore-forming protein that acts as a downstream mediator of granzyme-mediated cell death and mediates pyroptosis of human cells . Following cleavage and activation by granzyme A (GZMA), the N-terminal part binds to membrane inner leaflet lipids, homooligomerizes within the human plasma membrane and forms pores of 10-15 nanometers (nm) of inner diameter, triggering pyroptosis . .; FUNCTION: [Isoform 1]: Precursor of a pore-forming protein that acts as a downstream mediator of granzyme-mediated cell death and specifically mediates cell death of Gram-negative bacteria in response to infection . Following cleavage and activation by granzyme A (GZMA), the N-terminal part recognizes and binds phospholipids found on Gram-negative bacterial membranes, such as lipid A and cariolipin, homooligomerizes within the bacterial membranes and forms pores, triggering pyroptosis followed by cell death . In contrast to isoform 4, does not bind to membrane inner leaflet lipids of host human cell, such as phosphatidylinositol 4-phosphate, phosphatidylinositol 5-phosphate, bisphosphorylated phosphatidylinositols, such as phosphatidylinositol (4,5)-bisphosphate . .; FUNCTION: [Isoform 2]: Not able to trigger pyroptosis. .; FUNCTION: [Isoform 3]: Not able to trigger pyroptosis. . |
Accessions | ENST00000394175.6 [Q8TAX9-2] B2CM71 ENST00000523371.5 ENST00000468820.1 B2CM72 ENST00000418519.6 [Q8TAX9-4] ENST00000309481.11 [Q8TAX9-3] ENST00000524039.5 ENST00000520542.5 [Q8TAX9-6] ENST00000522564.5 J3QLF0 B2CM73 Q8TAX9 ENST00000394179.5 [Q8TAX9-3] ENST00000360317.7 [Q8TAX9-4] |